NCT05804786 Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions
| NCT ID | NCT05804786 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Bundang Hospital |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,240 participants |
| Start Date | 2023-04-01 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,240 participants in total. It began in 2023-04-01 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective is To evaluate the usefulness and safety of advanced guided bronchoscopy for histological diagnosis of peripheral pulmonary lesions. The Secondary objective is to establish a strategy that can most effectively use endoscopes for early diagnosis of lung cancer in a real-world care environment by identifying patient/clinical/image/procedure-related characteristics that can optimize the practicality of emerging technologies.
Eligibility Criteria
Inclusion Criteria: 1. Patients who agreed in writing to participate in this study 2. Adult men and women over 19 years of age 3. Patients who visited the hospital with lung lesions suspected of lung cancer and require a diagnostic biopsy 4. Patients capable of biopsy through guided bronchoscopy Exclusion Criteria: 1\) Patients who are unable to express their opinions and cannot cooperate due to a lack of cognitive function
Contact & Investigator
Yeon Wook Kim, MD., PhD
PRINCIPAL INVESTIGATOR
Seoul National University Bundang Hospital
Frequently Asked Questions
Who can join the NCT05804786 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05804786 currently recruiting?
Yes, NCT05804786 is actively recruiting participants. Contact the research team at kimyw@snu.ac.kr for enrollment information.
Where is the NCT05804786 trial being conducted?
This trial is being conducted at Daegu, South Korea, Gyeonggi-do, South Korea, Hwasun, South Korea, Ilsan, South Korea and 7 additional locations.
Who is sponsoring the NCT05804786 clinical trial?
NCT05804786 is sponsored by Seoul National University Bundang Hospital. The principal investigator is Yeon Wook Kim, MD., PhD at Seoul National University Bundang Hospital. The trial plans to enroll 1,240 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.